Please see enclosed Annual Report of the Company for the financial year March 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Auro Laboratories has submitted its Annual Report for the financial year ended March 31, 2025, along with the Notice of its 36th Annual General Meeting scheduled for September 25, 2025 via video conferencing. The AGM agenda includes adoption of audited financial statements, re-appointment of Whole Time Director Mr. Siddhartha Deorah (retiring by rotation), appointment of M/s B.L. Dasharda & Associates as new Statutory Auditors for a 5-year term (FY 2025-26 to FY 2029-30) following the resignation of M/s Kothari Jain & Associates, ratification of Cost Auditor remuneration of Rs. 60,000 for FY 2025-26, re-appointment of Independent Director Mrs. Kavita Vijayakant Sharma for 5 years, and appointment of GMJ & Associates as Secretarial Auditors for 5 years. The company also saw changes in CFO and Company Secretary positions during the year.
The mid-year change in statutory auditors (from Kothari Jain & Associates to B.L. Dasharda & Associates) is a notable governance event that shareholders should review. Otherwise, the filing is a routine regulatory submission with standard AGM business items including director re-appointments and auditor confirmations.